J.P. Morgan analyst Kian Abouhossein maintained a Buy rating on Goldman Sachs Group (GS – Research Report) yesterday and set a price target of $604.00. The company’s shares closed yesterday at ...

MS also said that rising recession risk could make Goldman's Apple Card portfolio worth less, given 36% of GS credit card book have less than 660 FICO score. J&J Earnings Preview: Pharmaceutical ...

It's hard to imagine T.J. Watt in anything other than Steelers black and gold, but it's a reality Pittsburgh fans might need to come to terms with. While there is no official word on what the ...

If someone forwarded you this email, sign up for free here. What is your favorite Dr. J memory? Email us back for a chance to be featured in the newsletter. For the first time in his major league ...

Nucor (NYSE:NUE – Get Free Report) had its price objective decreased by stock analysts at The Goldman Sachs Group ... Marshall & Sterling Wealth Advisors Inc. purchased a new position in Nucor ...

Goldman Sachs made significant rating changes ... However, the firm lowered its price target on LLY to $888 from $892 per share. Upgrading J&J (NYSE:JNJ) to Buy from Neutral, Haider argued that ...

which could work in J&J's favor. Goldman raised its 12-month price target to $172 from $157. On the flip side, AbbVie was downgraded to Neutral. Haider noted that investors already seem to have ...

which could work in J&J's favor. Goldman raised its 12-month price target to $172 from $157. On the flip side, AbbVie was downgraded to Neutral. Haider noted that investors already seem to have priced ...

J.P. Morgan Private Bank posted Asia’s largest AUM increase of 29.5 percent, or $49 billion, to hit $215 billion. Together with Morgan Stanley Private Wealth Management (15.1 percent increase to $175 ...

and there is nothing that can be done," wrote Judge J. Harvie Wilkinson III. Letters to both Sullivan & Cromwell and Kirkland probe potential recruitment efforts by the firms looking to poach ...

and there is nothing that can be done," wrote Judge J. Harvie Wilkinson III. Letters to both Sullivan & Cromwell and Kirkland probe potential recruitment efforts by the firms looking to poach ...

Goldman Sachs assumed coverage of Johnson & Johnson ... Consensus estimates are underappreciating the trajectory of the J&J’s Innovative Medicine business as the company laps the Stalera cliff ...